Sign in
Not yet taking people in United StatesNo phase

Care pathway to improve insomnia treatment for veterans with mild traumatic brain injury

Tests a care pathway for insomnia in veterans with mild traumatic brain injury.

Key facts

Who runs it
VA Office of Research and Development
Where
Aurora and Tampa, United StatesSee the 2 sites
Trial code
Registry title
Sleep MAPP in the Polytrauma/TBI System of Care
Status
Not yet recruiting
People taking part
900 people, planned
Starts
1 Jan 2027
Expected to end
31 Dec 2029
Type of study
Interventional
Treatments tested
  • Sleep MAPP Care Pathway
Record updated
21 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for Veterans with mild traumatic brain injury who get care at a VA Polytrauma clinic, many with insomnia. It also includes clinic staff who help run a new sleep care pathway.

Age
18 years and older
Sex
All sexes
Disease stage
Mild traumatic brain injury, diagnosed in routine care. For one part, insomnia with an Insomnia Severity Index score of 11 or higher.
Earlier treatment
For one part, Veterans must have started Brief Behavioral Therapy for Insomnia at the clinic and finished it no more than 1 week before being invited.
Biomarker or test result
Insomnia Severity Index score of 11 or higher (for one part of the trial).

Main reasons for not taking part

  • People who do not meet all the entry conditions cannot join

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Aim 1 Provider participants (study procedures aimed at understanding feasibility and acceptability)
  • Multidisciplinary member of the Polytrauma Network Site who is involved in implementation of the Sleep MAPP Care Pathway (e.g., program leadership, referring clinicians, and clinicians eligible for Brief Behavioral Therapy for Insomnia training); Aim 1 Veteran participants (study procedures aimed at understanding feasibility and acceptability)
  • Clinician-confirmed mild traumatic brain injury documented in the Comprehensive TBI Evaluation Database
  • Received the Insomnia Severity Index
  • Initiated Brief Behavioral Therapy for Insomnia at the Polytrauma Network Site and completed Brief Behavioral Therapy for Insomnia no more than 1 week before being invited to participate; Aim 2 Provider participants (study procedures aimed at understanding reach, adoption, implementation, and maintenance)
  • Multidisciplinary member of the Polytrauma Network Site who is involved in implementation of the Sleep MAPP Care Pathway, including referring clinicians and clinicians eligible for Brief Behavioral Therapy for Insomnia training; Aim 2 Veteran participants (study procedures aimed at understanding reach, adoption, implementation, and maintenance)
  • History of mild traumatic brain injury, diagnosed during routine clinical care
  • Scheduled to receive care at the Polytrauma Network Site; Aim 3 Veteran participants (study procedures aimed at understanding change in clinical outcomes after Brief Behavioral Therapy for Insomnia delivery)
  • History of mild traumatic brain injury, diagnosed during routine clinical care
  • Insomnia Severity Index score of 11 or higher

Who cannot take part

  • Does not meet all inclusion criteria

Where in United States

  • Rocky Mountain Regional VA Medical Center, Aurora, COAurora, United StatesContact: Adam R Kinney, PhD OTRNot yet recruiting
  • James A. Haley Veterans' Hospital, Tampa, FLTampa, United StatesContact: Praveen K Gootam, PhDNot yet recruiting

About the trial

What the trial wants to find out

This pilot implementation trial will evaluate the Sleep Disorder Management Assistance for Providers and Patients (Sleep MAPP) Care Pathway in one Veterans Health Administration Polytrauma/TBI System of Care clinic. The care pathway combines a provider-facing decision-support tool that supports pre-visit administration and documentation of the Insomnia Severity Index with training and implementation support for clinic providers to deliver Brief Behavioral Therapy for Insomnia. The study will assess the feasibility and acceptability of the care pathway; describe changes in guideline-concordant insomnia screening and behavioral treatment; and describe preliminary changes in insomnia symptoms, neurobehavioral symptoms, and participation in social roles among Veterans with mild traumatic brain injury who receive Brief Behavioral Therapy for Insomnia. Up to 30 clinic providers or staff and 50 Veterans will be invited to complete research surveys and interviews. Implementation and clinical outcomes will be obtained from routinely collected clinical data.

The group in the trial

  • Sleep MAPP Care PathwayTreatment being tested

    The participating Polytrauma/TBI System of Care clinic will implement the Sleep MAPP Care Pathway, which is designed to increase delivery of two guideline-recommended clinical practices: insomnia screening with the Insomnia Severity Index and Brief Behavioral Treatment for Insomnia (BBTI). Implementation will be supported by a multicomponent strategy bundle that includes deployment of the Sleep MAPP clinical decision support tool, training providers to deliver BBTI, and complementary implementation supports.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Sleep MAPP: A Tool to Improve Insomnia Disorder Treatment Among Veterans Receiving Polytrauma/TBI System of Care Services
Plain-language title
Care pathway to improve insomnia treatment for veterans with mild traumatic brain injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 October 2026